At present, the National Institute on Drug Abuse (NIDA) has a monopoly on the production of
marijuana for legitimate medical and research purposes in the United States. Judge Bittner found
this monopoly to be unjustified, since federal law clearly requires adequate competition in the
manufacture of Schedule I and I1 substances. (See 21 U.S.C.
$ 823(a)(1); see also 21 C.F.R. 8
1301.33(b).)
As one of your predecessors, DEA Administrator Robert Bonner, stated, "Those who insist that
marijuana has medical uses would serve society better by promoting or sponsoring more
legitimate scientific research, rather than throwing their time, money and rhetoric into lobbying
public relations campaigns and perennial litigation." We urge you to accept Judge Bittner's
recommendation that it would be in the public interest for DEA to grant Prof. Craker's
application for registration as a bulk manufacturer so that such legitimate and privately-funded
scientific research will be conducted.
No comments:
Post a Comment